Matinas BioPharma Holdings, Inc.
MTNB
$0.19
$0.001.20%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 74.72% | -16.00% | 77.33% | 64.16% | 8.29% |
| Total Depreciation and Amortization | -96.72% | -42.19% | -61.54% | -54.51% | -49.38% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -103.52% | 438.10% | -88.43% | -73.86% | 268.62% |
| Change in Net Operating Assets | 19.33% | 126.60% | -359.30% | 29.98% | -133.92% |
| Cash from Operations | 9.15% | 20.23% | 57.01% | 57.89% | 34.93% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -97.00% | -96.68% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -- | -600.00% | 100.00% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.06% | -- | 5,900.00% | 195.52% | -82.35% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -360.40% | -344.72% | 52.31% | -117.93% | -112.69% |